Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer

NCT00006099 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped low study accrual

Conditions

Ovarian Cancer

Interventions

BIOLOGICAL: Monoclonal antibody hu3S193

Sponsor

Ludwig Institute for Cancer Research

Collaborators

[object Object]